2-((3-Fluorophenyl)amino)-4-methyl-1,3-thiazole-5-carboxylic acid, 95%, 2g

N-(3-pyridinylmethyl)-1-butanamine hydrochloride, 95.0%, 1g

4,4,5,5-Tetramethyl-2-(5-nitronaphthalen-1-yl)-1,3,2-dioxaborolane, 97%, 1g

Pipette holder base, 1 piece

N-[(5-Chloro-2-hydroxyphenyl)phenylmethylene]-L-valine, 97%, 250mg

Boron nitride rod 10 mm diameter 250 mm

Ethyl n-(2-cyanophenyl)carbamate, 97%, 100mg

1-Methyl-1H-indazol-5-yl-5-boronic acid, 97.0%, 250mg

EDTA dipotassium salt dihydrate, min. 99%, for synthesis, 500 g, plastic packaging.

(2R,4R)-1-(TERT-BUTOXYCARBONYL)-4-(DIFLUOROMETHOXY)PYRROLIDINE-2-CARBOXYLIC ACID, 95%, 5g

(S)-tert-butyl 6-(hydroxymethyl)-2,2-dimethylmorpholine-4-carboxylate, 95.0%, 250mg

n-Cyclopropylcyclohexanecarboxamide, 98%, 1g

3-Hydroxyphenyl Benzoate>95.0%(GC)100g